Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Key Driver in Gastric Cancer Progression Uncovered
August 2025
A new review highlights the growing role of fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein in gastric and gastroesophageal junction (G/GEJ) adenocarcinomas.
Read more
22 Oct 2021
Two Subtypes of Metastatic Prostate Cancer Identified
Scientists have identified two subtypes of metastatic prostate cancer that responding differently to treatment.
22 Oct 2021
Physical Activity Shows Evidence of Cancer Prevention in the USA
Engaging in 5 hours per week of moderate-intensity exercise could prevent 46,000 cancer cases annually in the USA.
26 Jul 2021
COVID-19 Immunity Delayed in Cancer Patients
Recent evidence has shown that cancer patients lack seropositivity following a single dose of the Pfizer-BioNTech mRNA COVID-19 vaccine. This urges the need for patients undergoing cancer treatment to be prioritised in the vaccine scheme, as their protection against the virus is delayed, relative to a healthy population.
26 Jul 2021
Moderate Alcohol Consumption Linked to Higher Risk of Cancer Development
SURPRISING new evidence has emerged suggesting a strong link between alcohol consumption and an increased risk of developing certain cancers.
23 Apr 2021
What Factors Predict Severe Reactions from Immunotherapy?
PREDICTING which patients with cancer may be at risk of severe side effects from immunotherapy may be improved through the identification of specific risk..
23 Apr 2021
Safety Tests Passed for Personalised Cancer Vaccine
VACCINE therapies for cancers have been a focus for developments in personalised medicine, and a recent Phase I trial has shown promising results…
29 Jan 2021
New Discovery in Specific Histone Deacetylase Inhibitor Development
EXCITING research from a team at the University of Copenhagen, Copenhagen, Denmark, has revealed molecular details of enzymes known as…
29 Jan 2021
Telaglenastat Enhances Combination Radiation Therapy by 40%
HEAD and neck cancer, like any cancer, is truly life-altering,” said Dr Christina Wicker, who is part of a group of researchers from…
Loading posts...
« Previous
1
…
27
28
29
30
31
…
52
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View